Published 2002 | Version v1
Journal article

The role of bisphosphonates in breast cancer: Direct effects of bisphosphonates on breast cancer cells

  • 1. Department of Oncology, Gastroenterology, Endocrinology, and Metabolism, St George's Hospital Medical School, Cranmer Terrace, London (United Kingdom)

Description

In addition to inhibiting bone resorption, bisphosphonates have also been shown to exhibit antitumour effects. In vitro, bisphosphonates inhibit proliferation and induce apoptosis in cultured human breast cancer cells. In addition, bisphosphonate treatment interferes with breast cancer cell adhesion to bone matrix, and inhibits cell migration and invasion. The combination of bisphosphonates with other anticancer drugs such as the taxoids markedly enhances these effects. These newly recognized direct actions of bisphosphonates on breast cancer cells indicate that these agents may have a greater role to play in treatment of patients suffering from cancers with a propensity to metastasize to bone

Availability note (English)

Available from http://dx.doi.org/10.1186/bcr412; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC138711

Additional details

Publishing Information

Journal Title
Breast Cancer Research (Print)
Journal Volume
4
Journal Issue
1
Journal Page Range
p. 18-23
ISSN
1465-5411

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47007040
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ADHESION; ANTINEOPLASTIC DRUGS; APOPTOSIS; IN VITRO; MAMMARY GLANDS; NEOPLASMS; SKELETON
Descriptors DEC
BODY; DISEASES; DRUGS; GLANDS; ORGANS

Optional Information

Copyright
Copyright (c) 2002 BioMed Central Ltd
Notes
PMCID: PMC138711; PUBLISHER-ID: bcr412; PMID: 11879555; OAI: oai:pubmedcentral.nih.gov:138711